Development of anti-tuberculosis vaccine using cytokine gene-transduced dendritic cells
Development of anti-tuberculosis vaccine using cytokine gene-transduced dendritic cells
批准号:
15590803
负责人:
SUDA Takafumi
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
在本研究中,我们评估了抗原85A (Ag85A)转导的树突状细胞(DCs)抗结核分枝杆菌疫苗。用分枝杆菌Ag85A逆转录病毒转导小鼠骨髓源性dc,并静脉注射到BALB/c小鼠。该dc疫苗能够产生纯化的蛋白衍生物(PPD)-,并能从脾脏细胞中产生抗原特异性的脾脏细胞增殖和ifn - γ。此外,DC疫苗诱导细胞毒性t淋巴细胞(CTL)表现出Ag85A分子上特异性CTL表位的裂解活性和ifn - γ产生。这种诱导细胞免疫导致了对结核分枝杆菌的中度保护性免疫的诱导
英文摘要
In the present study, we evaluated antigen 85A (Ag85A)-transduced dendritic cells (DCs) vaccine against Mycobacterium tuberculosis. Murine bone marrow-derived DCs were retrovirally transduced with mycobacterial Ag85A and injected to BALB/c mice intravenously. The DCs vaccine was capable of generating purified protein derivative (PPD)-, and the antigen-specific spleen cell proliferation and IFN-gamma production from the spleen cells. In addition, the DC vaccination induced cytotoxic T-lymphocytes (CTL) exhibiting lytic activity and IFN-gamma production specific to a CTL epitope on Ag85A molecule. This eliciting cellular immunity led to induction of moderate protective immunity against Mycobacterium tuberculosis
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
DOI:
--
发表时间:
2005
期刊:
American journal of respiratory cell and molecular biology
影响因子:
6.4
作者:
[H. Matsuda;T. Suda;J. Sato;T. Nagata;Y. Koide;K. Chida;Hirotoshi Nakamura]
通讯作者:
H. Matsuda;T. Suda;J. Sato;T. Nagata;Y. Koide;K. Chida;Hirotoshi Nakamura
Nakamura Y, et al.: "Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene"Infect Immun. 71. 1748-1754 (2003)
Nakamura Y等人:“用细胞毒性T淋巴细胞表位小基因逆转录病毒转导的树突状细胞诱导对单核细胞增生李斯特氏菌的保护性免疫”感染免疫。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Differences in clinical features and prognosis of interstitial pneumonia between Polymyositis and dermatomyositis
多发性肌炎与皮肌炎间质性肺炎临床特征及预后的差异
DOI:
--
发表时间:
2005
期刊:
J Rheumatol 32
影响因子:
--
作者:
[Fujisawa T, Suda T, et al.]
通讯作者:
et al.
DOI:
10.1159/000082465
发表时间:
2004-01-01
期刊:
ANNALS OF NUTRITION AND METABOLISM
影响因子:
3.9
作者:
[Miyake, Y, Sasaki, S, Tanaka, H]
通讯作者:
Tanaka, H
The incidence and clinical charactaristics of bronchiolitis obliterans organizing pneumonia syndrome after radiation therapy for breast cancer
乳腺癌放射治疗后闭塞性细支气管炎机化性肺炎综合征的发生率及临床特点
DOI:
--
发表时间:
2004
期刊:
Sarcoidosis Vasc Diffuse Lung Dis 21
影响因子:
--
作者:
[Miwa S, Suds T, et al.]
通讯作者:
et al.
共 13 条
Novel dendritic cell vaccine for tuberculosis with inhibition of indoleamine 2, 3-dioxygenase.
-
批准号:21590985
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:SUDA Takafumi
-
依托单位:
Development of dendritic cell vaccine modified with a ligand of NKT cells against tuberculosis
-
批准号:19590888
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:SUDA Takafumi
-
依托单位:
Intratracheal injection of dendritic cells loaded with cytotoxic T cell epitope of intracellular pathogen efficiently induces epitope-specific T cells and confers protective immunity
-
批准号:17590784
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:SUDA Takafumi
-
依托单位:
Development of DC-vaccine against tuberclulosis
-
批准号:13670595
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2001
-
负责人:SUDA Takafumi
-
依托单位:
Involvement of dendritic cells in pulmonary granuloma formation elicited by BCG in rats
-
批准号:11670572
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1999
-
负责人:SUDA Takafumi
-
依托单位:
国内基金
海外基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
-
批准号:31600836
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:杨俊华
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位:
胰腺癌MUC4抗原多表位嵌合DNA疫苗的设计和免疫研究
-
批准号:30500492
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:高文涛
-
依托单位: